Latest Plc Systems Inc. (PLCSF) Headlines PLC
Post# of 8
Posted On: 03/11/2014 12:24:30 AM
Latest Plc Systems Inc. (PLCSF) Headlines
PLC's RenalGuard System Used in Two Live Cases That Were Broadcast at TCT 2013 Meeting
Marketwire - Tue Nov 05, 7:08AM CST
PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that its lead product, RenalGuard® System was successfully used in two live cases that were transmitted via satellite to an audience of several hundred interventional cardiologist at the annual Transcatheter Cardiovascular Therapeutics (TCT) 2013 meeting in San Francisco last week. This marks the first time PLC's RenalGuard System was demonstrated on a live case at TCT. TCT is the world's largest educational meeting focused on interventional cardiovascular medicine and showcases the latest advances in current therapies and clinical research to improve patient care.
PLC Receives Approval From Japanese Ministry of Health, Labor and Welfare (MHLW) to Conduct 60-Patient Clinical Trial
Marketwire - Wed Oct 16, 7:18AM CDT
PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the initiation of a clinical trial in Japan using RenalGuard Therapy®. The Japanese MHLW granted this approval after reviewing previously published studies of RenalGuard Therapy and data from two cases where Japanese physicians used RenalGuard® to protect patients at risk of Contrast-Induced Acute Kidney Injury (CI-AKI). RenalGuard is currently CE-Marked and being distributed throughout Europe to prevent AKI.
PLC Systems Raises $1.75 Million in Equity Financing
Marketwire - Wed Sep 18, 3:05PM CDT
PLC Systems Inc. (OTCQB: PLCSF), a company focused on innovative medical device technologies, today reported that it has raised $1.75 million in gross proceeds through the sale of 29,166,668 shares of common stock at a purchase price of $0.06 per share and five-year warrants to purchase 29,166,668 shares of common stock at an exercise price of $0.08 per share. PLC Systems plans to use the proceeds from this financing to fund the ongoing U.S. pivotal trial with RenalGuard® during imaging procedures and for general corporate purposes.
RenalGuard Therapy Being Used in Hospital Initiated Study
Marketwire - Wed Sep 11, 7:00AM CDT
PLC Systems Inc. (OTCQB: PLCSF), a company focused on innovative medical device technologies, today announced that the first patient has been treated in a trial that has been initiated at Tel Aviv Sourasky Medical Center in Israel by Dr. Yaron Arbel, the Director of the hospital's Cardio Vascular Research Center. The trial is expected to enroll up to 200 patients and is the largest study designed to evaluate the effectiveness of RenalGuard Therapy(R) at preventing acute kidney injury (AKI) in patients undergoing Transcatheter Aortic Valve Implantation (TAVI).
OTC Daily Alert Stock Watch - PLC Systems Inc., (OTCQB: PLCSF)
WorldStockWire - Fri Sep 06, 10:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
PerkinElmer Launches SCID Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 03, 12:50PM CDT
PerkinElmer is dedicated in offering products and systems for prenatal clinical problems
Covidien Wins Patent Lawsuit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 30, 12:40PM CDT
Applied Medical sued Covidien for selling some trocar products that infringe its patent
Covidien Opens R&D Center in Korea - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 28, 3:14PM CDT
The center known as Covidien Center of Innovation Korea or CCI Korea intends to raise awareness of various diseases
Hanger Acquires $10M Annualized Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 26, 12:50PM CDT
With this, HGR completed half of its 2013 goal to acquire $20 million in annualized sales
athenahealth Partners with PCDC - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 23, 12:50PM CDT
ATHN and PCDC will conduct seminars across the U.S. to educate PCPs about their services meeting their Health IT
PerkinElmer Launches Preeclampsia Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 21, 9:20AM CDT
PerkinElmer is dedicated in offering products and systems for prenatal clinical problems
PLC Systems President and CEO Publishes New Blog Entitled â??AKI: What it means to PLC and Youâ?
ACCESSWIRE - Tue Aug 20, 7:32AM CDT
PLC Systems Inc. (OTCQB: PLCSF) today published a new blog post on The Chairman's Blog, written by the company's President and CEO, Mark Tauscher. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
PLC Systems Reports Second Quarter 2013 Financial Results
Marketwire - Wed Aug 14, 3:06PM CDT
PLC Systems Inc. (OTCQB: PLCSF), a medical device company focused on innovative technologies for the cardiac and vascular markets, today reported financial results for the three months and six months ended June 30, 2013. Highlights of the second quarter and recent weeks include:
PLC Systems President and CEO Publishes New Blog Entitled â??Welcome to the PLC Blogâ??
ACCESSWIRE - Wed Jul 10, 9:45AM CDT
PLC Systems Inc. (OTCQB: PLCSF) today published a new blog post on The Chairman's Blog, written by the company's President and CEO, Mark Tauscher. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
PLC Systems Expands Its Suite of Corporate Communication Channels
Marketwire - Wed Jul 10, 7:15AM CDT
PLC Systems Inc. (OTCQB: PLCSF), a company focused on innovative medical device technologies, today announced the launch of a featured profile on TheChairmansBlog.com and a new Executive Video featuring President & CEO, Mark R. Tauscher.
PLC Systems Receives Key U.S. Method Patent for RenalGuard(R)
Marketwire - Thu Jun 06, 7:01AM CDT
PLC Systems Inc. (OTCQB: PLCSF), a company focused on innovative medical device technologies, today announced it has been granted a new method patent by the U.S Patent and Trademark Office entitled, "Patient Hydration Method." The patent claims cover the use of RenalGuard Therapy® and the RenalGuard® device to protect patients' kidneys from therapeutic agents that are potentially toxic to the kidney, such as those used in the treatment of cancer or serious infections. This patent greatly expands PLC's intellectual property position. The company's existing core patents cover the use of the RenalGuard technology to reduce the risk of Acute Kidney Injury (AKI) from exposure to contrast agents which specifically lead to Contrast-Induced Acute Kidney Injury or CI-AKI.
RenalGuard Therapy(R) Shows Promise in TAVI Procedures
Marketwire - Tue May 28, 8:45AM CDT
PLC Systems Inc. (OTCQB: PLCSF), a company focused on innovative medical device technologies, today announced that Dr. Vaikom Mahadevan presented RenalGuard® data during the Interventions for Structure Heart Disease session at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). The data presented supports the further development of RenalGuard Therapy® to minimize Acute Kidney Injury (AKI) in patients undergoing Transcatheter Aortic Valve Implantation (TAVI) procedures.
Int'l Sales Ramping Nicely. Maintaining Outperform - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 16, 1:17PM CDT
Int'l Sales Ramping Nicely. Maintaining Outperform
PLC Systems Demonstrating RenalGuard(R) at EuroPCR2013
Marketwire - Thu May 16, 7:01AM CDT
PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced it will demonstrate its product, RenalGuard®, at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroPCR attracts more than 11,000 clinicians and medical professionals from around the world. The meeting will take place in Paris, France from May 21-24, 2013.
PLC Systems Reports First Quarter 2013 Financial Results
Marketwire - Wed May 15, 3:05PM CDT
PLC Systems Inc. (OTCBB: PLCSF), a medical device company focused on innovative technologies for the cardiac and vascular markets, today reported financial results for the three months ended March 31, 2013. Highlights of the first quarter and recent weeks include:
PLC's RenalGuard System Used in Two Live Cases That Were Broadcast at TCT 2013 Meeting
Marketwire - Tue Nov 05, 7:08AM CST
PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that its lead product, RenalGuard® System was successfully used in two live cases that were transmitted via satellite to an audience of several hundred interventional cardiologist at the annual Transcatheter Cardiovascular Therapeutics (TCT) 2013 meeting in San Francisco last week. This marks the first time PLC's RenalGuard System was demonstrated on a live case at TCT. TCT is the world's largest educational meeting focused on interventional cardiovascular medicine and showcases the latest advances in current therapies and clinical research to improve patient care.
PLC Receives Approval From Japanese Ministry of Health, Labor and Welfare (MHLW) to Conduct 60-Patient Clinical Trial
Marketwire - Wed Oct 16, 7:18AM CDT
PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the initiation of a clinical trial in Japan using RenalGuard Therapy®. The Japanese MHLW granted this approval after reviewing previously published studies of RenalGuard Therapy and data from two cases where Japanese physicians used RenalGuard® to protect patients at risk of Contrast-Induced Acute Kidney Injury (CI-AKI). RenalGuard is currently CE-Marked and being distributed throughout Europe to prevent AKI.
PLC Systems Raises $1.75 Million in Equity Financing
Marketwire - Wed Sep 18, 3:05PM CDT
PLC Systems Inc. (OTCQB: PLCSF), a company focused on innovative medical device technologies, today reported that it has raised $1.75 million in gross proceeds through the sale of 29,166,668 shares of common stock at a purchase price of $0.06 per share and five-year warrants to purchase 29,166,668 shares of common stock at an exercise price of $0.08 per share. PLC Systems plans to use the proceeds from this financing to fund the ongoing U.S. pivotal trial with RenalGuard® during imaging procedures and for general corporate purposes.
RenalGuard Therapy Being Used in Hospital Initiated Study
Marketwire - Wed Sep 11, 7:00AM CDT
PLC Systems Inc. (OTCQB: PLCSF), a company focused on innovative medical device technologies, today announced that the first patient has been treated in a trial that has been initiated at Tel Aviv Sourasky Medical Center in Israel by Dr. Yaron Arbel, the Director of the hospital's Cardio Vascular Research Center. The trial is expected to enroll up to 200 patients and is the largest study designed to evaluate the effectiveness of RenalGuard Therapy(R) at preventing acute kidney injury (AKI) in patients undergoing Transcatheter Aortic Valve Implantation (TAVI).
OTC Daily Alert Stock Watch - PLC Systems Inc., (OTCQB: PLCSF)
WorldStockWire - Fri Sep 06, 10:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
PerkinElmer Launches SCID Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 03, 12:50PM CDT
PerkinElmer is dedicated in offering products and systems for prenatal clinical problems
Covidien Wins Patent Lawsuit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 30, 12:40PM CDT
Applied Medical sued Covidien for selling some trocar products that infringe its patent
Covidien Opens R&D Center in Korea - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 28, 3:14PM CDT
The center known as Covidien Center of Innovation Korea or CCI Korea intends to raise awareness of various diseases
Hanger Acquires $10M Annualized Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 26, 12:50PM CDT
With this, HGR completed half of its 2013 goal to acquire $20 million in annualized sales
athenahealth Partners with PCDC - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 23, 12:50PM CDT
ATHN and PCDC will conduct seminars across the U.S. to educate PCPs about their services meeting their Health IT
PerkinElmer Launches Preeclampsia Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 21, 9:20AM CDT
PerkinElmer is dedicated in offering products and systems for prenatal clinical problems
PLC Systems President and CEO Publishes New Blog Entitled â??AKI: What it means to PLC and Youâ?
ACCESSWIRE - Tue Aug 20, 7:32AM CDT
PLC Systems Inc. (OTCQB: PLCSF) today published a new blog post on The Chairman's Blog, written by the company's President and CEO, Mark Tauscher. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
PLC Systems Reports Second Quarter 2013 Financial Results
Marketwire - Wed Aug 14, 3:06PM CDT
PLC Systems Inc. (OTCQB: PLCSF), a medical device company focused on innovative technologies for the cardiac and vascular markets, today reported financial results for the three months and six months ended June 30, 2013. Highlights of the second quarter and recent weeks include:
PLC Systems President and CEO Publishes New Blog Entitled â??Welcome to the PLC Blogâ??
ACCESSWIRE - Wed Jul 10, 9:45AM CDT
PLC Systems Inc. (OTCQB: PLCSF) today published a new blog post on The Chairman's Blog, written by the company's President and CEO, Mark Tauscher. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
PLC Systems Expands Its Suite of Corporate Communication Channels
Marketwire - Wed Jul 10, 7:15AM CDT
PLC Systems Inc. (OTCQB: PLCSF), a company focused on innovative medical device technologies, today announced the launch of a featured profile on TheChairmansBlog.com and a new Executive Video featuring President & CEO, Mark R. Tauscher.
PLC Systems Receives Key U.S. Method Patent for RenalGuard(R)
Marketwire - Thu Jun 06, 7:01AM CDT
PLC Systems Inc. (OTCQB: PLCSF), a company focused on innovative medical device technologies, today announced it has been granted a new method patent by the U.S Patent and Trademark Office entitled, "Patient Hydration Method." The patent claims cover the use of RenalGuard Therapy® and the RenalGuard® device to protect patients' kidneys from therapeutic agents that are potentially toxic to the kidney, such as those used in the treatment of cancer or serious infections. This patent greatly expands PLC's intellectual property position. The company's existing core patents cover the use of the RenalGuard technology to reduce the risk of Acute Kidney Injury (AKI) from exposure to contrast agents which specifically lead to Contrast-Induced Acute Kidney Injury or CI-AKI.
RenalGuard Therapy(R) Shows Promise in TAVI Procedures
Marketwire - Tue May 28, 8:45AM CDT
PLC Systems Inc. (OTCQB: PLCSF), a company focused on innovative medical device technologies, today announced that Dr. Vaikom Mahadevan presented RenalGuard® data during the Interventions for Structure Heart Disease session at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). The data presented supports the further development of RenalGuard Therapy® to minimize Acute Kidney Injury (AKI) in patients undergoing Transcatheter Aortic Valve Implantation (TAVI) procedures.
Int'l Sales Ramping Nicely. Maintaining Outperform - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 16, 1:17PM CDT
Int'l Sales Ramping Nicely. Maintaining Outperform
PLC Systems Demonstrating RenalGuard(R) at EuroPCR2013
Marketwire - Thu May 16, 7:01AM CDT
PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced it will demonstrate its product, RenalGuard®, at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroPCR attracts more than 11,000 clinicians and medical professionals from around the world. The meeting will take place in Paris, France from May 21-24, 2013.
PLC Systems Reports First Quarter 2013 Financial Results
Marketwire - Wed May 15, 3:05PM CDT
PLC Systems Inc. (OTCBB: PLCSF), a medical device company focused on innovative technologies for the cardiac and vascular markets, today reported financial results for the three months ended March 31, 2013. Highlights of the first quarter and recent weeks include:
(0)
(0)Viveve Medical Inc. (PLCSD) Stock Research Links
Scroll down for more posts ▼